Category:
Description:
Indications:
-
Serious
infections (P. aeruginosa,
Proteus species, E. coli,
Klebsiella species,
Enterobacter species,
Serratia species, Citrobacter species,
Staphylococcus species)
-
Bacterial
neonatal sepsis
-
Bacterial
septicemia
-
Serious
bacterial infections of the CNS (meningitis)
-
Urinary
tract, respiratory tract, skin, bone and soft tissue (including burns)
infections
-
Gram-negative
infections
-
Emperic
therapy for unknown serious infections
Contraindications:
Precautions:
-
Pregnancy
category D
-
May
cause nephrotoxicity, therefore closely monitor renal function,
especially in elderly patients.
-
May
cause ototoxicity, therefore monitor hearing
-
Monitor
peak and trough serum concentrations
-
In
patients with extensive burns, altered pharmacokinetics may alter
serum concentrations.
-
May
produce hypomagnesemia, especially if poor or restricted diet.
-
Aminoglycosides
have neuromuscular blockade activity with a curare-like effect.
Monitor patient’s neuromuscular function, especially in
patients with myasthenia gravis, parkinsonism or infant botulism.
Adverse
Reactions (Side Effects):
-
Central
and peripheral nervous system reactions:
-
Headache
-
Depression
-
Confusion
-
Lethargy
-
Muscle
twitching
-
Peripheral
neuropathy
-
Gastrointestinal:
vomiting, nausea, anorexia, hypersalivation
-
Hematologic:
changes in reticulocyte counts, anemia, altered WBC counts
-
Hypersensitivity:
rash, urticaria, itching
-
Special
senses: dizziness, tinnitis, vertigo
-
Renal:
oliguria, proteinuria, increased creatinine and BUN
-
Miscellaneous:
apnea, alopecia, joint pain
-
Pain
at injection site
-
Decreased
calcium, sodium, potassium and magnesium levels
|
Dosage:
Adults:
normal
renal function: 3mg/kg/day IV or IM in 3 equal doses every 8 hours |
Weight
(pounds) |
Weight
(kg) |
Q8 hour Dose (Moderate Infections) |
132 |
60 |
60 mg IM/IV |
154 |
70 |
70 mg IM/IV |
176 |
80 |
80 mg IM/IV |
198 |
90 |
90 mg IM/IV |
Serious infections:
5mg/kg/day divided into 3-4 equal doses |
Weight
(pounds) |
Weight
(kg) |
Q8 hour Dose (Serious Infections) |
132 |
60 |
100 mg IM/IV |
154 |
70 |
117 mg IM/IV |
176 |
80 |
133 mg IM/IV |
198 |
90 |
150 mg IM/IV |
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|